Cyclerion Therapeutics Inc Ordinary Shares (NASDAQ:CYCN)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CYCN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CYCN

  • Market Cap$109.360m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS23255M1053

Company Profile

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Latest CYCN news

Currently there for this company. Visit our news hub for other news .